Leukemia Treatment Based on CRISPR Genome-Editing Technology

Abstract

By reviewing the literature and summarizing and refining it, this research investigated the various ways in which CRISPR gene editing technology can treat the leukemia pathology, and this research will look forward to the future application of CRISPR-based gene editing technology. At present, there are two main ways to apply CRISPR technology to influence leukemia treatment. The first is to directly knock out a known disease-causing gene to inhibit the proliferation of harmful cells, thus delaying the disease and realizing the purpose of leukemia treatment. The other is to indirectly inhibit leukemia by inserting a certain gene through the CRISPR gene editing technology to achieve the inhibition of the expression of disease-causing genes. However, the current direction of research by using CRISPR technology to explore the pathogenesis of leukemia and disease-causing genes is relatively small. In the future, more research and experiments can be conducted to explore the pathogenesis and causative genes of leukemia by applying CRISPR technology.